Caplin Point Laboratories
Caplin Point Laboratories on Friday announced an investment in its injectables subsidiary, Caplin Steriles, by Eight Roads Ventures, the proprietary i18-01-2019
18-01-2019
CAPLIN POINT LABORATORIES LTD. - 524742 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 313142 Name of the Signatory :- Vinod Kumar SDesignation :- Company Secretary and Compliance Officer18-01-2019
Caplin Point Laboratories Ltd - 524742 - Outcome of Board Meeting
Outcome of the Board Meeting18-01-2019
CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Intimation for Business Transfer Agreement.
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/01/2019 ,inter alia, to consider and approve the Business Transfer Agreement to be entered into with its Wholly Owned Subsidiary Company, Caplin Steriles Limited, for transfer of business undertaking of the Company (Regulated Markets Injectable Business, including US FDA approved Injectable Plant and DSIR recognized R&D; Units CP4 and CP5), besides considering other allied subjects pursuant to the approval granted by the members of the Company through Postal Ballot.18-01-2019
Caplin Point Laboratories Ltd - 524742 - Board Meeting Intimation for Considering And Approving The Investment In The Wholly Owned Subsidiary Company, Caplin Steriles Limited By A Global Financial Investor With Strong Healthcare Experience.
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/01/2019 ,inter alia, to consider and approve the Investment by a global financial investor with strong healthcare experience in the Wholly Owned Subsidiary Company, Caplin Steriles Limited. Further, the trading window continues to remain closed until January 20, 2019 for Promoters, Directors, other Connected Persons and Employees of the Company as per the Company's Code of Conduct to regulate, monitor and report trading by insiders adopted by the Board pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.11-01-2019
Caplin Point Laboratories Ltd - 524742 - Outcome of Board Meeting
Pursuant to approval of the Members of the Company through Postal Ballot, the Board of Directors of the Company at their meeting held today, have considered and approved the Business Transfer Agreement to be entered into with its Wholly Owned Subsidiary Company, Caplin Steriles Limited for transfer of business undertaking of the Company (Regulated Markets Injectable Business, including US FDA approved Injectable Plant and DSIR recognized R&D; Units CP4 and CP5) by way of slump sale on a going concern basis.11-01-2019
Caplin Point Laboratories Ltd - 524742 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Caplin Point Laboratories Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here01-01-2019
CAPLIN POINT LABORATORIES LTD. - 524742 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Caplin Point Laboratories Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here01-01-2019
CAPLIN POINT LABORATORIES LTD. - 524742 - DECLARATIONS OF RESULTS OF VOTING CONDUCTED BY POSTAL BALLOT
DECLARATIONS OF RESULTS OF VOTING CONDUCTED BY POSTAL BALLOT31-12-2018